$AGX
ARGAN INC

2024 Q2 Form 10-Q Financial Statement

#000155837024008969 Filed on June 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $157.7M
YoY Change 52.09%
Cost Of Revenue $139.7M
YoY Change 56.22%
Gross Profit $17.94M
YoY Change 26.15%
Gross Profit Margin 11.38%
Selling, General & Admin $11.43M
YoY Change 7.87%
% of Gross Profit 63.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $480.0K
YoY Change -12.25%
% of Gross Profit 2.67%
Operating Expenses $11.43M
YoY Change 7.87%
Operating Profit $6.519M
YoY Change 79.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.794M
YoY Change -862.16%
Pretax Income $11.31M
YoY Change 276.6%
Income Tax $3.431M
% Of Pretax Income 30.33%
Net Earnings $7.882M
YoY Change 273.73%
Net Earnings / Revenue 5.0%
Basic Earnings Per Share $0.59
Diluted Earnings Per Share $0.58
COMMON SHARES
Basic Shares Outstanding 13.24M
Diluted Shares Outstanding 13.57M

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $416.4M
YoY Change 83.97%
Cash & Equivalents $207.7M
Short-Term Investments $208.6M
Other Short-Term Assets $43.63M
YoY Change 2.95%
Inventory $9.573M
Prepaid Expenses $9.595M
Receivables $59.96M
Other Receivables $18.25M
Total Short-Term Assets $574.3M
YoY Change 35.14%
LONG-TERM ASSETS
Property, Plant & Equipment $10.83M
YoY Change 1.5%
Goodwill $28.03M
YoY Change 0.0%
Intangibles $2.120M
YoY Change -15.57%
Long-Term Investments $1.400M
YoY Change 27.27%
Other Assets $2.305M
YoY Change -36.08%
Total Long-Term Assets $50.08M
YoY Change -1.21%
TOTAL ASSETS
Total Short-Term Assets $574.3M
Total Long-Term Assets $50.08M
Total Assets $624.4M
YoY Change 31.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.45M
YoY Change 82.88%
Accrued Expenses $60.72M
YoY Change 35.67%
Deferred Revenue $200.4M
YoY Change 80.07%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $327.6M
YoY Change 70.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $3.655M
YoY Change -31.66%
Total Long-Term Liabilities $3.655M
YoY Change -31.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $327.6M
Total Long-Term Liabilities $3.655M
Total Liabilities $331.3M
YoY Change 67.52%
SHAREHOLDERS EQUITY
Retained Earnings $229.4M
YoY Change 11.03%
Common Stock $166.9M
YoY Change 1.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $97.73M
YoY Change 8.73%
Treasury Stock Shares
Shareholders Equity $293.2M
YoY Change
Total Liabilities & Shareholders Equity $624.4M
YoY Change 31.26%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income $7.882M
YoY Change 273.73%
Depreciation, Depletion And Amortization $480.0K
YoY Change -12.25%
Cash From Operating Activities $17.69M
YoY Change -1517.15%
INVESTING ACTIVITIES
Capital Expenditures $322.0K
YoY Change -50.08%
Acquisitions
YoY Change
Other Investing Activities -$1.406M
YoY Change -104.78%
Cash From Investing Activities -$1.728M
YoY Change -106.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.118M
YoY Change -21.19%
NET CHANGE
Cash From Operating Activities 17.69M
Cash From Investing Activities -1.728M
Cash From Financing Activities -5.118M
Net Change In Cash 10.71M
YoY Change -51.34%
FREE CASH FLOW
Cash From Operating Activities $17.69M
Capital Expenditures $322.0K
Free Cash Flow $17.36M
YoY Change -1017.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000100591
CY2024Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2024Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
ARGAN INC
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
18252000
CY2024Q2 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current Statement Of Financial Position Extensible List
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#Investments
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
187000
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-04-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity File Number
EntityFileNumber
001-31756
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1947195
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
One Church Street, Suite 201
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2024Q2 dei City Area Code
CityAreaCode
301
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
315-0027
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.15 par value
CY2024Q2 dei Trading Symbol
TradingSymbol
AGX
CY2024Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13354332
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157682000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103675000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
139738000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
89451000
CY2024Q2 us-gaap Gross Profit
GrossProfit
17944000
CY2023Q2 us-gaap Gross Profit
GrossProfit
14224000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11425000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10591000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6519000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3633000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4794000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-629000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11313000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3004000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3431000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
895000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
7882000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2109000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-790000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
440000
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-969000
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-37000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6123000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2512000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13257000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13413000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13572000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13546000
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207738000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
197032000
CY2024Q2 us-gaap Investments
Investments
208618000
CY2024Q1 us-gaap Investments
Investments
215373000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59960000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47326000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
54385000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
48189000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
43625000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
39259000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
574326000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
547179000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10825000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11021000
CY2024Q2 us-gaap Goodwill
Goodwill
28033000
CY2024Q1 us-gaap Goodwill
Goodwill
28033000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2120000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2217000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2305000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2259000
CY2024Q2 agx Operating Lease Right Of Use Asset And Other Assets
OperatingLeaseRightOfUseAssetAndOtherAssets
6799000
CY2024Q1 agx Operating Lease Right Of Use Asset And Other Assets
OperatingLeaseRightOfUseAssetAndOtherAssets
7520000
CY2024Q2 us-gaap Assets
Assets
624408000
CY2024Q1 us-gaap Assets
Assets
598229000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
66448000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
39485000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60721000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
81721000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200429000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
181054000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
327598000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
302260000
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3655000
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5030000
CY2024Q2 us-gaap Liabilities
Liabilities
331253000
CY2024Q1 us-gaap Liabilities
Liabilities
307290000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15828289
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15828289
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13350180
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13242520
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2374000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2374000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164501000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164183000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
229364000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
225507000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2478109
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2585769
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
97728000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
97528000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5356000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3597000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
293155000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
290939000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
624408000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
598229000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
290939000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
7882000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-790000
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-969000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1211000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-906000
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
187000
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4025000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293155000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
280897000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
2109000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
440000
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-37000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1034000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
544000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3681000
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3357000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
277949000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
7882000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
2109000
CY2024Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3544000
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1081000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1211000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1034000
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
647000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
439000
CY2024Q2 us-gaap Depreciation
Depreciation
480000
CY2023Q2 us-gaap Depreciation
Depreciation
547000
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
263000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
147000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
97000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
98000
CY2024Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
38000
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-57000
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12636000
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10642000
CY2024Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
6196000
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-19864000
CY2024Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4422000
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4089000
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7479000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26940000
CY2024Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
19375000
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
15047000
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17686000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1248000
CY2024Q2 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
57500000
CY2023Q2 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
90000000
CY2024Q2 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
80000000
CY2023Q2 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
149750000
CY2024Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
29824000
CY2023Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
30355000
CY2024Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9230000
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
322000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
645000
CY2024Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3312000
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1728000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28750000
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
187000
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3681000
CY2024Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4025000
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3357000
CY2024Q2 agx Proceeds From Share Based Award Settlements Net Of Withholding Taxes Paid
ProceedsFromShareBasedAwardSettlementsNetOfWithholdingTaxesPaid
-906000
CY2023Q2 agx Proceeds From Share Based Award Settlements Net Of Withholding Taxes Paid
ProceedsFromShareBasedAwardSettlementsNetOfWithholdingTaxesPaid
544000
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5118000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6494000
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-134000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
992000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10706000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22000000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197032000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173947000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207738000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195947000
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
542000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
293000
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3312000
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
513000
CY2024Q2 agx Operating Leases Paid
OperatingLeasesPaid
651000
CY2023Q2 agx Operating Leases Paid
OperatingLeasesPaid
444000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157682000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103675000
CY2024 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
66500000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
50900000
CY2024Q2 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
24800000
CY2024Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
21200000
CY2024Q2 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
9400000
CY2024Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
8400000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
800000000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.67
CY2024Q2 agx Accrued Investment Income Dividend Receivable
AccruedInvestmentIncomeDividendReceivable
600000
CY2024Q1 agx Accrued Investment Income Dividend Receivable
AccruedInvestmentIncomeDividendReceivable
700000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
84029000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
109489000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
124589000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
105884000
CY2024Q2 us-gaap Investments
Investments
208618000
CY2024Q1 us-gaap Investments
Investments
215373000
CY2024Q2 agx Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Within One Year
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearWithinOneYear
14865000
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
125639000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1050000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
124589000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
105623000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
568000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
307000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
105884000
CY2024Q2 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent
800000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
1300000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1000000.0
CY2023Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2024Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
CY2024Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
CY2024Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
4500000
CY2023Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2400000
CY2024Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1800000
CY2024Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1800000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5415000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3295000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2120000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5415000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3198000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2217000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
294000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
376000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
300000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
300000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
300000
CY2024Q2 agx Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
550000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2120000
CY2024Q2 agx Remaining Bonded Performance Obligations
RemainingBondedPerformanceObligations
400000000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1200000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1000000.0
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8000000.0
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1365000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.95
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M1D
CY2024Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.43
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6000
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.22
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
249000
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
41.58
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
60.07
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1118000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.73
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M19D
CY2024Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.63
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1047000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
46.13
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M8D
CY2024Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
10.81
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1118000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
45.73
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y5M19D
CY2024Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstandings Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingsWeightedAverageGrantDateFairValue
10.63
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
92000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.85
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.89
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
27000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
8.63
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
71000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.06
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4700000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
700000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17800000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16400000
CY2024Q2 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
2658
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2376000
CY2023Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
631000
CY2024Q2 agx Unrecognized Tax Loss Benefit
UnrecognizedTaxLossBenefit
-794000
CY2024Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-216000
CY2023Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-198000
CY2024Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
418000
CY2023Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
84000
CY2024Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
59000
CY2023Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
378000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3431000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
895000
CY2021Q1 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
12700000
CY2024Q2 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
5800000
CY2024Q2 agx Unrecognizedtaxbenefitsincreaseresultingfromresearchanddevelopmenttaxcredit
Unrecognizedtaxbenefitsincreaseresultingfromresearchanddevelopmenttaxcredit
2400000
CY2024Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
18300000
CY2024Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3300000
CY2024Q2 agx Cash Investment Commitments
CashInvestmentCommitments
0
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1400000
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
2100000
CY2024Q2 agx Amortization Of Equity Investments In Solar Energy Projects
AmortizationOfEquityInvestmentsInSolarEnergyProjects
700000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4794000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
7882000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2109000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13257000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13413000
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
315000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
133000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13572000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13546000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
344000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
851834
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
5600
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
92656
CY2024Q2 us-gaap Share Price
SharePrice
44.87
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3700000
CY2023Q2 us-gaap Share Price
SharePrice
39.61
CY2024Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
185354
CY2024Q2 agx Share Based Payment Arrangement Average Price Per Share Of Shares Withheld For Tax Withholding Obligation
ShareBasedPaymentArrangementAveragePricePerShareOfSharesWithheldForTaxWithholdingObligation
60.64
CY2024Q2 agx Treasury Stock Settlement Of Stock Option Exercises And Other Share Based Awards
TreasuryStockSettlementOfStockOptionExercisesAndOtherShareBasedAwards
113260
CY2023Q2 agx Treasury Stock Settlement Of Stock Option Exercises And Other Share Based Awards
TreasuryStockSettlementOfStockOptionExercisesAndOtherShareBasedAwards
65470
CY2024Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157682000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
139738000
CY2024Q2 us-gaap Gross Profit
GrossProfit
17944000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11425000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6519000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11313000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3431000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
7882000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
97000
CY2024Q2 us-gaap Depreciation
Depreciation
480000
CY2024Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
322000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
574326000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
327598000
CY2024Q2 us-gaap Goodwill
Goodwill
28033000
CY2024Q2 us-gaap Assets
Assets
624408000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103675000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
89451000
CY2023Q2 us-gaap Gross Profit
GrossProfit
14224000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10591000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3633000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-629000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3004000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
895000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
2109000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
98000
CY2023Q2 us-gaap Depreciation
Depreciation
547000
CY2023Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
645000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
425001000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
192397000
CY2023Q2 us-gaap Goodwill
Goodwill
28033000
CY2023Q2 us-gaap Assets
Assets
475694000
CY2024Q2 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
18252000
CY2024Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
18267000
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
9573000
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
9985000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9595000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6035000
CY2024Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
6205000
CY2024Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4972000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
43625000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
39259000
CY2024Q2 agx Accrued Project Costs Current
AccruedProjectCostsCurrent
30855000
CY2024Q1 agx Accrued Project Costs Current
AccruedProjectCostsCurrent
49135000
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
13991000
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
21206000
CY2024Q2 agx Accrued Lease Liabilities Current
AccruedLeaseLiabilitiesCurrent
3282000
CY2024Q1 agx Accrued Lease Liabilities Current
AccruedLeaseLiabilitiesCurrent
2726000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12593000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8654000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60721000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
81721000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-008969-index-headers.html Edgar Link pending
0001558370-24-008969-index.html Edgar Link pending
0001558370-24-008969.txt Edgar Link pending
0001558370-24-008969-xbrl.zip Edgar Link pending
agx-20240430.xsd Edgar Link pending
agx-20240430x10q.htm Edgar Link pending
agx-20240430x10q001.jpg Edgar Link pending
agx-20240430xex31d1.htm Edgar Link pending
agx-20240430xex31d2.htm Edgar Link pending
agx-20240430xex32d1.htm Edgar Link pending
agx-20240430xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
agx-20240430_cal.xml Edgar Link unprocessable
agx-20240430_def.xml Edgar Link unprocessable
agx-20240430_lab.xml Edgar Link unprocessable
agx-20240430_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agx-20240430x10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending